Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma.
Müller J, Krijgsman O, Tsoi J, Robert L, Hugo W, Song C, Kong X, Possik PA, Cornelissen-Steijger PD, Geukes Foppen MH, Kemper K, Goding CR, McDermott U, Blank C, Haanen J, Graeber TG, Ribas A, Lo RS, Peeper DS.
Müller J, et al. Among authors: robert l.
Nat Commun. 2014 Dec 15;5:5712. doi: 10.1038/ncomms6712.
Nat Commun. 2014.
PMID: 25502142
Free PMC article.